Mp49-02 a Study to Evaluate the Prognostic and Predictive Utility of CCP and HRD Assays and Genetic Sequencing in Patients Undergoing Neoadjuvant Chemotherapy in Bladder Cancer
Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.415
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)